BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9029440)

  • 41. The treatment of myopia with atropine and bifocals. A long-term prospective study.
    Brodstein RS; Brodstein DE; Olson RJ; Hunt SC; Williams RR
    Ophthalmology; 1984 Nov; 91(11):1373-9. PubMed ID: 6514306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atropine slows myopia progression more in Asian than white children by meta-analysis.
    Li SM; Wu SS; Kang MT; Liu Y; Jia SM; Li SY; Zhan SY; Liu LR; Li H; Chen W; Yang Z; Sun YY; Wang N; Millodot M
    Optom Vis Sci; 2014 Mar; 91(3):342-50. PubMed ID: 24445721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does atropine use increase intraocular pressure in myopic children?
    Wu TE; Yang CC; Chen HS
    Optom Vis Sci; 2012 Feb; 89(2):E161-7. PubMed ID: 22105331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students.
    Kennedy RH; Dyer JA; Kennedy MA; Parulkar S; Kurland LT; Herman DC; McIntire D; Jacobs D; Luepker RV
    Binocul Vis Strabismus Q; 2000; 15(3 Suppl):281-304. PubMed ID: 11486796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progression of myopia.
    Kennedy RH
    Trans Am Ophthalmol Soc; 1995; 93():755-800. PubMed ID: 8719698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of 0.01% atropine combined with orthokeratology lens in delaying juvenile myopia: An observational study.
    Guo Y; Liu Y; Hu Z; Li Y; Zhang H; Zhao S
    Medicine (Baltimore); 2024 Jun; 103(24):e38384. PubMed ID: 38875374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of low-concentration atropine combined with auricular acupoint stimulation in myopia control.
    Cheng HC; Hsieh YT
    Complement Ther Med; 2014 Jun; 22(3):449-55. PubMed ID: 24906584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of atropine 0.01% on myopia control in children aged 6-13 years during the 2022 lockdown in Shanghai.
    Yu M; Jiang L; Chen M
    Front Public Health; 2023; 11():1074272. PubMed ID: 36778567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of treatment response about low-dose (0.01%) atropine eye-drops in myopic children.
    Jeon GS; Hong IH; Lee JH; Song TG; Lee TY; Han JR
    Eur J Ophthalmol; 2022 Jul; 32(4):2011-2017. PubMed ID: 34399596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Atropine Eye Drops in Myopia Control.
    Grzybowski A; Armesto A; Szwajkowska M; Iribarren G; Iribarren R
    Curr Pharm Des; 2015; 21(32):4718-30. PubMed ID: 26350533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atropine treatment for myopia.
    Brown SM
    Ophthalmology; 2009 Oct; 116(10):2040; author reply 2040-1. PubMed ID: 19800530
    [No Abstract]   [Full Text] [Related]  

  • 52. Myopia Control: A Review.
    Walline JJ
    Eye Contact Lens; 2016 Jan; 42(1):3-8. PubMed ID: 26513719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term effect of atropine on higher-order aberrations in myopic children.
    Kuo YS; Yen MY; Lin PY
    J Chin Med Assoc; 2021 Apr; 84(4):441-445. PubMed ID: 33496515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Combined method for treating false myopia and preventing axial myopia].
    Tokueva RZh; Batmanov IuE
    Vestn Oftalmol; 1998; 114(6):33-5. PubMed ID: 9951384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Real-world outcomes of low-dose atropine therapy on myopia progression in an Australian cohort during the COVID-19 pandemic.
    Usmani E; Callisto S; Chan WO; Taranath D
    Clin Exp Ophthalmol; 2023 Nov; 51(8):775-780. PubMed ID: 37648227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effect of atropine 1% in children with low myopia.
    Yi S; Huang Y; Yu SZ; Chen XJ; Yi H; Zeng XL
    J AAPOS; 2015 Oct; 19(5):426-9. PubMed ID: 26228967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.
    Ebri A; Kuper H; Wedner S
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Part-time use of 1% atropine eye drops for prevention of myopia progression in children.
    Foo LL; Htoon H; Farooqui SZ; Chia A
    Int Ophthalmol; 2020 Jul; 40(7):1857-1862. PubMed ID: 32266643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The cycloplegic effect of atropine in comparison with the cyclopentolate-tropicamide-phenylephrine combination].
    Alimgil ML; Erda N
    Klin Monbl Augenheilkd; 1992 Jul; 201(1):9-11. PubMed ID: 1513131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study.
    Chia A; Li W; Tan D; Luu CD
    Doc Ophthalmol; 2013 Jun; 126(3):177-86. PubMed ID: 23292524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.